Day One Biopharmaceuticals, Inc.
DAWNDelisted Apr 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001845337
Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in Day One Biopharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
DAWN is no longer listed, and 13F filings after Q1 2026 list far fewer holders. See Q1 2026
- Institutional holders
- 1
- −204 vs. Q1 2026
- Shares held
- 165
- −86.3M (−100.0%) vs. Q1 2026
- Total value
- $3.55K
- −$1.84B (−100.0%) vs. Q1 2026
- New holders
- 0
- 0 more added
- Sold out
- 204
- 1 more reduced
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DAWN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $3.55K |
| Q1 2026 | 208 | $1.85B |
| Q4 2025 | 184 | $758.4M |
| Q3 2025 | 173 | $603.5M |
| Q2 2025 | 174 | $561.1M |
| Q1 2025 | 184 | $747.1M |
| Q4 2024 | 164 | $1.19B |
| Q3 2024 | 166 | $1.28B |
| Q2 2024 | 157 | $1.03B |
| Q1 2024 | 148 | $1.20B |
| Q4 2023 | 139 | $1.12B |
| Q3 2023 | 130 | $951.5M |
| Q2 2023 | 140 | $941.0M |
| Q1 2023 | 126 | $818.1M |
| Q4 2022 | 109 | $1.29B |
| Q3 2022 | 93 | $1.21B |
| Q2 2022 | 87 | $1.06B |
| Q1 2022 | 66 | $429.6M |
| Q4 2021 | 58 | $698.3M |
| Q3 2021 | 45 | $452.9M |
| Q2 2021 | 33 | $401.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Day One Biopharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |
| Sunbelt Securities, Inc. | – | – | – | – | Not filed |